Discriminating organic carbon from endokarstic moonmilk-type deposits by LIBS. The case of a natural carbonated Martian analogue.

Moonmilk-type deposits exemplify carbonated Martian analogues existing in the subsurface of Earth, an endokarstic speleothem with a possible biochemical origin composed principally by carbonates, mainly huntite and dolomite. In this work, samples of moonmilk located in Nerja Cave (southern Spain) have been studied by LIBS with the aim of identifying carbon of biogenic origin by establishing a relationship between a molecular emission indicator, CN signal, and the organic carbon content. The characterization of this kind of carbonate deposit with a multiple mineralogical composition has been completed using scanning electron microscopy (SEM), energy dispersive X-ray (EDX) and X-ray diffraction techniques for qualitative and semi-quantitative analysis. The information attained from LIBS regarding energy thresholds and time-resolved kinetics of CN emissions provides useful insight into the identification of different molecular emitters, namely organic and inorganic CN, depending on the laser irradiance and time settings conditions. These promising results are of application in the search and identification of biosignatures in upcoming planetary missions with astrobiological purposes.

Multi-analytical characterization of an oncoid from a high altitude hypersaline lake using techniques employed in the Mars2020 and Rosalind Franklin missions on Mars.

In this work, a geological sample of great astrobiological interest was studied through analytical techniques that are currently operating in situ on Mars and others that will operate in the near future. The sample analyzed consisted of an oncoid, which is a type of microbialite, collected in the Salar Carachi Pampa, Argentina. The main peculiarity of microbialites is that they are organo-sedimentary deposits formed by the in situ fixation and precipitation of calcium carbonate due to the growth and metabolic activities of microorganisms. For this reason, the Carachi Pampa oncoid was selected as a Martian analog for astrobiogeochemistry study. In this sense, the sample was characterized by means of the PIXL-like, SuperCam-like and SHERLOC-like instruments, which represent instruments on board the NASA Perseverance rover, and by means of RLS-like and MOMA-like instruments, which represent instruments on board the future ESA Rosalind Franklin rover. It was possible to verify that the most important conclusions and discoveries have been obtained from the combination of the results. Likewise, it was also shown that Perseverance rover-like remote-sensing instruments allowed a first detailed characterization of the biogeochemistry of the Martian surface. With this first characterization, areas of interest for in-depth analysis with Rosalind Franklin-like instruments could be identified. Therefore, from a first remote-sensing elemental identification (PIXL-like instrument), followed by a remote-sensing molecular characterization (SuperCam and SHERLOC-like instruments) and ending with an in-depth microscopic analysis (RLS and MOMA-like instruments), a wide variety of compounds were found. On the one hand, the expected minerals were carbonates, such as aragonite, calcite and high-magnesium calcite. On the other hand, unexpected compounds consisted of minerals related to the Martian/terrestrial surface (feldspars, pyroxenes, hematite) and organic compounds related to the past biological activity related to the oncoid (kerogen, lipid biomarkers and carotenes). Considering samples resembling microbialites have already been found on Mars and that one of the main objectives of the missions is to identify traces of past life, the study of microbialites is a potential way to find biosignatures protected from the inhospitable Martian environment. In addition, it should be noted that in this work, further conclusions have been obtained through the study of the results as a whole, which could also be carried out on Mars.

Identificación de factores que se asocian a alto riesgo de desarrollar diabetes gestacional / Identification of factors associated with a high risk of developing gestational diabetes

Objetivos: Principal. Determinar la prevalencia de los factores de riesgo reconocidos para diabetes gestacional (DG) en nuestra población. Definir el perfil de las pacientes con mayor riesgo de desarrollar DG. Secundario. Analizar la aceptabilidad por parte de las gestantes de las pruebas de cribado. Material y método: Se trata de un estudio observacional ambispectivo en el que se reclutaron 1448 gestantes en un único centro, entre el 1 de diciembre de 2017 y el 31 de julio de 2019. Los criterios de inclusión fueron: no antecedente de diabetes mellitus pregestacional, no antecedente de DG en gestación previa, no antecedentes de cirugía bariátrica, haber realizado cribado para DG en la actual gestación. Resultados: La prevalencia de DG en nuestra población fue del 6,7%. Los factores de riesgo que se asociaron con el desarrollo de DG en nuestra población fueron: edad≥27,5 años (OR: 3,8; IC95%: 2,01-9,16), IMC≥28,5kg/m2 (OR: 2,3; IC95%:1,47-3,59); antecedente de diabetes mellitus en familiares de primer grado (OR: 2,3; IC95%: 1,5-3,66) y la gestación múltiple (OR: 2,8; IC95%: 0,86-6,36). La prevalencia de la DG se incrementó según lo hacía el número de factores de riesgo encontrados en la gestante: desde el 1,4% en las pacientes sin los factores de riesgo hasta el 25.2% con 3 factores de riesgo presentes. El 26,8% de las pacientes calificaron como desagradable la realización del test de ÓSullivan (50g glucosa) y el 65,4% la prueba de sobrecarga oral con 100g de glucosa. Conclusiones: La edad de la gestante≥27,5, el IMC≥28,5kg/m2, el antecedente de diabetes mellitus en familiares de primer y la gestación múltiple son factores que se asocian con alto riesgo de desarrollar DG; estos factores serían suficientes para identificar a la mayoría de las gestantes que desarrollarán DG. Nuestros resultados pueden aplicarse para mejorar los programas de atención prenatal destinados al diagnóstico y tratamiento precoz de la DG.(au)

Objectives: The main objective is to determine the current prevalence of recognised risk factors for gestational diabetes mellitus (GDM) in our region, and to define the profile of patients at higher risk of developing this condition. We also investigate patient acceptability of the screening tests. Material and methods: This is an ambispective study with 1,448 pregnant women recruited between December 2017 and July 2019 from a single centre. Inclusion criteria were no diabetes mellitus prior to the pregnancy, no history of GDM in any previous pregnancy, no history of bariatric surgery before the pregnancy, and GDM screening tests performed. Results: The prevalence of GDM was 6.7%. Risk factors associated with development of GDM were: age≥27.5 years (OR: 3.8; 95% CI: 2.01-9.16); BMI≥28.5kg/m2 (OR: 2.3; 95% CI: 1.47-3.59); history of diabetes mellitus in first-degree relatives (OR: 2.3; 95% CI: 1.5-3.66); and multiple pregnancy (OR: 2.8; 95% CI: 0.86-6.36); Prevalence of GDM increased with the number of risk factors presented by patients: from 1.4% with no risk factor, to 25.2% with 3. The O'Sullivan test (50g glucose) and oral glucose tolerance test (100g glucose) were perceived as “unpleasant” by 26.8% and 65.4% of patients, respectively. Conclusions: Age≥27.5 years, BMI≥28.5kg/m2, history of diabetes mellitus in first-degree relatives, and multiple pregnancy are factors related to an increased risk of GDM; these factors would be enough to identify most pregnant women developing GDM. Our findings may be used to improve programmes aimed at early diagnosis of gestational diabetes and supporting high-risk mothers in antenatal care.(AU)

Inverse metal-assisted chemical etching of germanium with gold and hydrogen peroxide.

Metal-assisted chemical etching (MACE) is a flexible technique for texturing the surface of semiconductors. In this work, we study the spatial variation of the etch profile, the effect of angular orientation relative to the crystallographic planes, and the effect of doping type. We employ gold in direct contact with germanium as the metal catalyst, and dilute hydrogen peroxide solution as the chemical etchant. With this catalyst-etchant combination, we observe inverse-MACE, where the area directly under gold is not etched, but the neighboring, exposed germanium experiences enhanced etching. This enhancement in etching decays exponentially with the lateral distance from the gold structure. An empirical formula for the gold-enhanced etching depth as a function of lateral distance from the edge of the gold film is extracted from the experimentally measured etch profiles. The lateral range of enhanced etching is approximately 10-20µm and is independent of etchant concentration. At length scales beyond a few microns, the etching enhancement is independent of the orientation with respect to the germanium crystallographic planes. The etch rate as a function of etchant concentration follows a power law with exponent smaller than 1. The observed etch rates and profiles are independent of whether the germanium substrate is n-type, p-type, or nearly intrinsic.

Tagetes lucida Cav. essential oil and the mixture of its main compounds are antibacterial and modulate antibiotic resistance in multi-resistant pathogenic bacteria.

We evaluated an essential oil (EO) of Tagetes lucida Cav. and the mixture of its main compounds against multi-drug resistant bacteria. We found that EO and the partially reconstituted blend of its main components have antibacterial activity and inhibit antibiotic resistance (ampicillin, chloramphenicol, nalidixic acid, vancomycin and imipenem) in strains of Staphylococcus aureus ATCC 29213 and Pseudomonas aeruginosa HIM-MR01. The T. lucida EO alone or added to the antibiotics showed antimicrobial activity against S. aureus and P. aeruginosa. The EO main bioactive compounds were methyl eugenol (relative abundance in EO: 46·15%), estragole (32·93%), linalool (2·48%) and geraniol (0·33%). The mixture (PREO) of those compounds at those proportions inhibited the growth of P. aeruginosa in 45% at 683·62 µg ml-1 and that of S. aureus in 51·7% at 39·04 µg ml-1 . The PREO had higher antibacterial and modulatory activities than the original EO. In conclusion, we overcame the unpredictability of EO activity (due to their natural variability) by determining which EO components inhibited bacteria and then producing a PREO to generate a reproducible mixture with predictable antibacterial and modulation of resistance activities. Thus, the PREO, and its components, show potential as alternatives to manage multidrug-resistant pathogens.

A mitochondrial analysis reveals distinct founder effect signatures in Canarian and Balearic goats.

In the course of human migrations, domestic animals often have been translocated to islands with the aim of assuring food availability. These founder events are expected to leave a genetic footprint that may be recognised nowadays. Herewith, we have examined the mitochondrial diversity of goat populations living in the Canarian and Balearic archipelagos. Median-joining network analysis produced very distinct network topologies for these two populations. Indeed, a majority of Canarian goats shared a single ancestral haplotype that segregated in all sampled islands, suggesting a single founder effect followed by a stepping-stone pattern of diffusion. This haplotype also was present in samples collected from archaeological assemblies at Gran Canaria and Lanzarote, making evident its widespread distribution in ancient times. In stark contrast, goats from Majorca and Ibiza did not share any mitochondrial haplotypes, indicating the occurrence of two independent founder events. Furthermore, in Majorcan goats, we detected the segregation of the mitochondrial G haplogroup that has only been identified in goats from Egypt, Iran and Turkey. This finding suggests the translocation of Asian and/or African goats to Majorca, possibly as a consequence of the Phoenician and Carthaginian colonisations of this island.

Manifestaciones neurológicas de la invaginación intestinal / Neurological symptoms in children with intussusception

INTRODUCCIÓN: La invaginación intestinal es una enfermedad obstructiva potencialmente grave que se produce cuando un segmento del intestino se introduce en el interior de otro segmento intestinal distal vecino. La tríada clásica de vómitos, dolor abdominal y hematoquecia aparece en menos de un 25% de los casos. Existen formas de presentación atípica, con clínica sistémica y/o neurológica predominante. La alteración brusca de la consciencia puede ser el único signo clínico en lactantes. OBJETIVOS: Conocer la frecuencia y la naturaleza de las manifestaciones neurológicas de la invaginación intestinal y describir las características específicas de este subgrupo de pacientes. PACIENTES Y MÉTODOS: Revisión retrospectiva de las historias clínicas de 351 niños diagnosticados de invaginación intestinal entre los años 2000 y 2012. En todos los pacientes analizamos: datos epidemiológicos generales, sintomatología digestiva y neurológica, duración del cuadro clínico y eficacia del tratamiento. RESULTADOS: En 15 de los 351 pacientes totales (4,27%) se recogieron distintos síntomas y signos neurológicos, destacando la letargia (66,66%), seguida por los episodios paroxísticos, hipotonía global, debilidad aguda y fluctuación del nivel de consciencia. Un 60% de estos pacientes tenían solo clínica neurológica y un 73,3% de ellos necesitaron cirugía. CONCLUSIONES: Se debe considerar la invaginación intestinal en el diagnóstico diferencial de los lactantes y niños pequeños que acuden al Servicio de Urgencias con cuadros de letargia, hipotonía, debilidad aguda, alteración brusca del nivel de conciencia y/o episodios paroxísticos, aunque no exista ninguno de los signos clásicos de presentación de la enfermedad. Un diagnóstico precoz en estos casos puede evitar el desarrollo de complicaciones vasculares intestinales irreversibles

INTRODUCTION: Intussusception is a potentially severe obstructive disease that occurs when amore proximal portion of bowel invaginates into a more distal part of the bowel. Patients with intussusception often present with a wide range of non-specific systemic symptoms, with less than one quarter presenting with the classic triad of vomiting, abdominal pain, and bloody stools. An acute change in level of consciousness could be the only clinical symptom of this disorder. OBJECTIVES: To ascertain the frequency and nature of the neurological symptoms in children with intussusception, and to describe the characteristics of the patients presenting in this atypical way. PATIENTS AND METHODS: We retrospectively reviewed the records of 351 children presenting with intussusception from 2000 to 2012. General epidemiological data, abdominal and neurological signs and symptoms, duration of symptoms and effectiveness of treatment, were analysed in all patients. RESULTS: Of the 351 patients studied, 15 (4.27%) had one or more neurological symptoms recorded at presentation, with lethargy being the most frequent (66.66%), followed by hypotonia, generalized weakness, paroxysmal events, and fluctuating consciousness. Sixty per cent of these fifteen patients showed isolated neurological symptomatology, and eleven of them (73.3%) needed a laparotomy to reduce the intussusception. CONCLUSIONS: Intussusception should be considered in the differential diagnosis in infants and young children presenting as a pediatric emergency with lethargy, hypotonia, generalized weakness, paroxysmal events and/or sudden changes in consciousness, even in the absence of the classical symptoms of intussusception. An early recognition of intussusception may improve the global prognosis and avoid ischaemic intestinal sequelae

[Neurological symptoms in children with intussusception]. / Manifestaciones neurológicas de la invaginación intestinal.

INTRODUCTION: Intussusception is a potentially severe obstructive disease that occurs when a more proximal portion of bowel invaginates into a more distal part of the bowel. Patients with intussusception often present with a wide range of non-specific systemic symptoms, with less than one quarter presenting with the classic triad of vomiting, abdominal pain, and bloody stools. An acute change in level of consciousness could be the only clinical symptom of this disorder. OBJECTIVES: To ascertain the frequency and nature of the neurological symptoms in children with intussusception, and to describe the characteristics of the patients presenting in this atypical way. PATIENTS AND METHODS: We retrospectively reviewed the records of 351 children presenting with intussusception from 2000 to 2012. General epidemiological data, abdominal and neurological signs and symptoms, duration of symptoms and effectiveness of treatment, were analysed in all patients. RESULTS: Of the 351 patients studied, 15 (4.27%) had one or more neurological symptoms recorded at presentation, with lethargy being the most frequent (66.66%), followed by hypotonia, generalized weakness, paroxysmal events, and fluctuating consciousness. Sixty per cent of these fifteen patients showed isolated neurological symptomatology, and eleven of them (73.3%) needed a laparotomy to reduce the intussusception. CONCLUSIONS: Intussusception should be considered in the differential diagnosis in infants and young children presenting as a pediatric emergency with lethargy, hypotonia, generalized weakness, paroxysmal events and/or sudden changes in consciousness, even in the absence of the classical symptoms of intussusception. An early recognition of intussusception may improve the global prognosis and avoid ischaemic intestinal sequelae.

Qualidade e quantidade do leite produzido por cabras da raça Saanen submetidas a estresse por três dias consecutivos / Quality and quantity of milk produced by Saanen goats submitted to stress during three sequential days

Estudou-se o efeito do estresse fisiológico, via administração pontual de ACTH, sobre os níveis de cortisol e a quantidade e qualidade do leite produzido. Para tanto, 12 cabras da raça Saanen foram alocadas em dois grupos experimentais: o grupo ACTH recebeu 0,6 UI de ACTH/kg PV, e o grupo placebo recebeu solução placebo. A produção de leite, os percentuais de proteína, gordura e lactose e a contagem de células somáticas (CCS) do leite foram mensurados antes, durante e após a administração de ACTH e do placebo. Simultaneamente à administração de ACTH e placebo por três dias consecutivos, foram realizadas colheitas de sangue para mensuração dos teores de cortisol. Nos tempos -30 e zero, ambos os grupos apresentaram concentrações basais de cortisol. O aumento nos níveis de cortisol foi significativo nos tempos 60min (grupo ACTH: 59,00±5,70 e grupo placebo: 5,23±1,37ng/mL) e 120min (grupo ACTH: 47,96±9,72 e grupo placebo: 4,38±1,14ng/mL), pois a concentração de cortisol foi maior no grupo ACTH. Os valores retornaram ao basal no tempo 300min. Não houve diferenças na produção leiteira entre os grupos ACTH e placebo, tampouco de proteína, gordura, lactose e CCS do leite dos grupos, portanto o estresse induzido por três dias consecutivos não trouxe prejuízos à produção.

The experiment aimed to study the effect of physiological stress on cortisol levels, quality and quantity of milk through punctual administration of ACTH. Twelve Saanen goats were divided in two experimental groups: ACTH group (0,5±g of ACTH/Kg.L.W); Placebo group (placebo solution). Milk production, and percentages of protein, fat, lactose and SCC (somatic cells counting) of the milk were analyzed before, during and after the administration of ACTH/placebo. Simultaneously to the ACTH/placebo administration and during three sequential days, blood was collected to evaluate cortisol concentrations. At times -30 and zero, both groups presented basal concentrations of cortisol. The increase of cortisol contents was significant at times 60 (group ACTH: 59.00±5.70 and groups placebo: 5.23±1.37ng/mL) and 120 (group ACTH: 47.96±9.72 and group placebo: 4.38±1,14ng/mL) since the cortisol content was higher on the ACTH group. The values returned to the basal level at 300 minutes. Concerning milk production, no differences were found between ACTH and placebo groups. Milk, protein, fat, lactose and SCC did not distinguish one group from another. The results indicated that the physiological stress induced during three days was not harmful to milk production and milk quality of Saanen goats.

Encefalopatía de Wernicke en pacientes no alcohólicos: una serie de 8 casos / Wernicke's encephalopathy in non-alcoholic patients: a series of 8 cases

Introduction: Wernicke's encephalopathy (WE) is an underdiagnosed condition, usually associated with alcoholism, and has a worse prognosis if there is a delay in diagnosis. A series of 8 non-alcoholic patients with WE is presented and an assessment is made on whether a delay in diagnosis leads to a worse prognosis. Patients and methods:The clinical records of patients admitted to 2 university hospitals between 2004 and 2009 with the diagnosis of WE, excluding those with a history of alcoholism, were retrospectively reviewed. Results:The study included 4 men and 4 women aged 35-82 of whom 7 had a history of gastrointestinal pathology, and persistent vomiting was the precipitating factor in 7. Encephalopathy was the most frequent onset symptom (4). The classical triad was present in seven patients. Thiamine levels were low in 3/6 and normal in 3/6 cases. MRI was abnormal in seven patients, with high signal intensity in the diencephalon and mammillary bodies (7), periaqueductal grey matter (6), cortex (3) and cerebellum (1). Seven improved with thiamine. Sequelae were mild in 6, and severe in 2 after 6-12 months of follow-up. All patients with a diagnostic delay less than 18 days had mild sequelae.Conclusions: Non-alcoholic WE frequently occurs after gastrointestinal disturbances that could result in lower thiamine absorption. Whereas thiamine levels can be normal in many cases, in almost all cases the MRI shows signal alterations in typical locations. A delay in the diagnosis, and therefore, in treatment leads to a worse prognosis

Introducción: La encefalopatía de Wernicke (EW) es una entidad infradiagnosticada, generalmente asociada a alcoholismo, que tiene peor pronóstico si existe retraso diagnóstico. Se presenta una serie de 8 pacientes no alcohólicos con EW y se evalúa si el retraso en el diagnóstico implica un peor pronóstico. Pacientes y métodos:Revisión retrospectiva de las historias clínicas de pacientes ingresados en dos hospitales universitarios entre 2004 y 2009 con diagnóstico de EW, excluidos aquéllos con historia de alcoholismo.Resultados: Se incluyó a 4 varones y 4 mujeres, con edades comprendidas entre los 35 y los 82 años; 7 tenían antecedentes patológicos gastrointestinales y los vómitos persistentes fueron el desencadenante en 7 casos. La encefalopatía fue la forma de inicio más frecuente (4 casos). La tríada clásica llegó a estar presente en 7 pacientes. Los niveles de tiamina fueron bajos en 3/6 y normales en 3/6 pacientes. La RM fue patológica en 7 pacientes, con hiperintensidad en diencéfalo y cuerpos mamilares (7), sustancia gris periacueductal (6), corteza (3) y cerebelo (1). Siete pacientes mejoraron tras el tratamiento con tiamina. Las secuelas fueron leves en 5 casos y graves en 3 pacientes. Todos los pacientes con un retraso diagnóstico inferior a 18 días tuvieron secuelas leves.Conclusiones: En la EW no alcohólica son frecuentes los antecedentes gastrointestinales que podrían condicionar una menor absorción de tiamina. Mientras que los niveles de tiamina pueden ser normales en muchos casos, la RM casi siempre muestra alteración de señal en localizaciones típicas. El retraso en el diagnóstico y, por tanto, en el tratamiento podría implicar un peor pronóstico (AU)

[Wernicke's encephalopathy in non-alcoholic patients: a series of 8 cases]. / Encefalopatía de Wernicke en pacientes no alcohólicos: una serie de 8 casos.

INTRODUCTION: Wernicke's encephalopathy (WE) is an underdiagnosed condition, usually associated with alcoholism, and has a worse prognosis if there is a delay in diagnosis. A series of 8 non-alcoholic patients with WE is presented and an assessment is made on whether a delay in diagnosis leads to a worse prognosis. PATIENTS AND METHODS: The clinical records of patients admitted to 2 university hospitals between 2004 and 2009 with the diagnosis of WE, excluding those with a history of alcoholism, were retrospectively reviewed. RESULTS: The study included 4 men and 4 women aged 35-82 of whom 7 had a history of gastrointestinal pathology, and persistent vomiting was the precipitating factor in 7. Encephalopathy was the most frequent onset symptom (4). The classical triad was present in seven patients. Thiamine levels were low in 3/6 and normal in 3/6 cases. MRI was abnormal in seven patients, with high signal intensity in the diencephalon and mammillary bodies (7), periaqueductal grey matter (6), cortex (3) and cerebellum (1). Seven improved with thiamine. Sequelae were mild in 6, and severe in 2 after 6-12 months of follow-up. All patients with a diagnostic delay less than 18 days had mild sequelae. CONCLUSIONS: Non-alcoholic WE frequently occurs after gastrointestinal disturbances that could result in lower thiamine absorption. Whereas thiamine levels can be normal in many cases, in almost all cases the MRI shows signal alterations in typical locations. A delay in the diagnosis, and therefore, in treatment leads to a worse prognosis.

[Comparison of the view of the glottic opening through Macintosh and AirTraq laryngoscopes in patients undergoing scheduled surgery]. / Comparación de la visión laringoscópica obtenida con los dispositivos Macintosh y AirTraq en pacientes de cirugía programada.

BACKGROUND AND OBJECTIVE: The AirTraq laryngoscope is a new intubation device that may provide better viewing conditions than can be achieved with the traditional Macintosh device. This study compared the AirTraq and Macintosh views and assessed whether predictors of intubation difficulty are useful when the AirTraq laryngoscope is used. MATERIAL AND METHODS: Prospective study of 215 ASA 1-3 patients over the age of 18 years who were to receive anesthesia with endotracheal intubation. Excluded were patients who required emergency surgery, who had a history of difficult intubation, or for whom ventilation was difficult during induction of anesthesia. In addition to the usual patient characteristics, we recorded thyromental distance, mouth opening, and Mallampati score. The Cormack-Lehane laryngoscopy grade was recorded for each device. A Cormack-Lehane grade of 1 or 2 was considered a good view. A grade of 3 or 4 was considered a poor view. The McNemar test was used to compare laryngoscopy grade between the 2 devices in each patient. The chi2 test was used to compare predictors of intubation difficulty. RESULTS: The Macintosh laryngoscope achieved a Cormack-Lehane grade of 1 in 653% of the patients, of 2 in 22.4%, of 3 in 11.3%, and of 4 in 1.4%. The AirTraq scope gave a Cormack-Lehane grade of 1 in 96.2%, of 2 in 33%, of 3 in 0.5%, and of 4 in 0%. The differences were statistically significant. None of the predictors was associated a poor glottic view through the AirTraq device. CONCLUSIONS: Poor viewing conditions occurred less frequently when the AirTraq device was used. Intubation conditions were therefore better with the AirTraq than with the Macintosh device. The traditional predictors of difficult intubation do not seem to be relevant when the AirTraq device is to be used.

Afección neurológica en la enfermedad de Whipple en forma de polineuropatía de fibra fina / Small-fibre polyneuropathy in Whipple’s disease

No disponible

Comparación de la visión laringoscópica obtenida con los dispositivos Macintosh y Airtraq en pacientes de cirugía programada / Comparison of the view of the glottic opening through Macintosh and AirTraq laryngoscopes in patients undergoing scheduled surgery

INTRODUCCIÓN: El laringoscopio Airtraq es un nuevodispositivo de intubación que puede proporcionar mejorescondiciones de visión frente al clásico Macintosh. Secompara la diferencia en la laringoscopia entre ambos:Airtraq y Macintosh; así como si los predictores de intubaciónson útiles para el Airtraq.MATERIAL Y MÉTODOS: Estudio prospectivo incluyendo215 pacientes, mayores de 18 años, ASA I-III, sometidosa anestesia con intubación endotraqueal. Se excluyóla cirugía urgente, los que habían presentado unaintubación difícil en episodios previos y la dificultad enla ventilación durante la inducción de anestesia. Seestudiaron los datos demográficos, antropométricos,distancia tiromentoniana, apertura bucal, Mallampatiy grado de visión laringoscópica Cormack-Lehane concada dispositivo. Se clasificó a los pacientes según sugrado de Cormack-Lehane como buena visión si lavisión era I o II y mala visión si era III o IV. Se utilizóla prueba de McNemar para comparar el grado devisión laringoscópica de ambos dispositivos en cadapaciente y ji-cuadrado en el caso de los predictores deintubación.RESULTADOS: La distribución según la visión laringoscópicacon Macintosh fue: Cormack-Lehane I 65,3%, II22,4%, III 11,3% y IV 1,4% y con Airtraq Cormack-Lehane I 96,2%, II 3,3%, III 0,5% y IV ninguno. Estasdiferencias fueron estadísticamente significativas. Ni ladistancia tiromentoniana, ni la apertura bucal, ni el gradode Mallampati se asociaron una mala visión laringoscópicacon Airtraq.CONCLUSIONES: El dispositivo Airtraq disminuyó elnúmero de laringoscopias con mala visión y como consecuenciaproporcionó mejores condiciones de intubaciónen relación al Macintosh. Además los predictores deintubación clásicos no parecieron tener utilidad cuandose utiliza el Airtraq(AU)

BACKGROUND AND OBJECTIVE: The AirTraqlaryngoscope is a new intubation device that mayprovide better viewing conditions than can be achievedwith the traditional Macintosh device. This studycompared the AirTraq and Macintosh views andassessed whether predictors of intubation difficulty areuseful when the AirTraq laryngoscope is used.MATERIAL AND METHODS: Prospective study of 215ASA 1-3 patients over the age of 18 years who were toreceive anesthesia with endotracheal intubation.Excluded were patients who required emergencysurgery, who had a history of difficult intubation, or forwhom ventilation was difficult during induction ofanesthesia. In addition to the usual patientcharacteristics, we recorded thyromental distance,mouth opening, and Mallampati score. The Cormack-Lehane laryngoscopy grade was recorded for eachdevice. A Cormack-Lehane grade of 1 or 2 wasconsidered a good view. A grade of 3 or 4 was considereda poor view. The McNemar test was used to comparelaryngoscopy grade between the 2 devices in eachpatient. The 2 test was used to compare predictors ofintubation difficulty.RESULTS: The Macintosh laryngoscope achieved aCormack-Lehane grade of 1 in 65.3% of the patients, of2 in 22.4%, of 3 in 11.3%, and of 4 in 1.4%. The AirTraqscope gave a Cormack-Lehane grade of 1 in 96.2%, of 2in 3.3%, of 3 in 0.5%, and of 4 in 0%. The differenceswere statistically significant. None of the predictors wasassociated a poor glottic view through the AirTraq device. CONCLUSIONS: Poor viewing conditions occurred lessfrequently when the AirTraq device was used.Intubation conditions were therefore better with theAirTraq than with the Macintosh device. The traditionalpredictors of difficult intubation do not seem to berelevant when the AirTraq device is to be used(AU)

Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life.

Symptom control, daily "on" time, and quality of life (QoL) of nine patients with Advanced Parkinson's Disease was assessed following 18-months treatment with Continuous Intraduodenal Levodopa Infusion (CIDLI). Patients had severe motor fluctuations and dyskinesias and had previously received treatment with oral levodopa and dopamine agonists. There were significant improvements in patients' symptoms on the Unified Parkinson's Disease Rating Scale, and QoL (Parkinson's Disease QoL Questionnaire; Schwab & England Capacity for Daily Living Scale; p < 0.05). Mean (+/-SD) daily "on" time increased from 6.1 +/- 1.9 to 12.0 +/- 3.4 h (p < 0.05). Improved QoL in APD was associated with CIDLI-related improvements in symptom control and increase in daily "on" time.